Cell Signaling Technology

Product Pathways - Motif Antibodies

Phospho-(Ser) CDKs Substrate Antibody #2324

Applications Reactivity Source
W IP IHC-P E-P All Rabbit

Applications Key:  W=Western Blotting  IP=Immunoprecipitation  IHC-P=Immunohistochemistry (Paraffin)  E-P=ELISA (Peptide)
Reactivity Key: All=All species expected

Specificity / Sensitivity

Phospho-(Ser) CDKs Substrate Antibody detects phospho-serine in a (K/R)(S*)PX(K/R) motif. The antibody is phospho-specific but does not recognize phospho-serine in the absence of the CDK motif. The antibody does not cross-react with phospho-threonine- or phospho-tyrosine-containing peptides/proteins. (U.S. Patent No's.: 6,441,140; 6,982,318; 7,259,022; 7,344,714; U.S.S.N. 11,484,485; and all foreign equivalents.)

Source / Purification

Polyclonal antibodies are produced by immunizing rabbits with synthetic phospho-CDK substrate peptides (KLH-coupled). Antibodies are purified by protein A and peptide affinity chromatography.

Western Blotting

Western Blotting

Western blot analysis of extracts from HeLa cells, untreated or treated with the microtubule destabilizing agents nocodazole or paclitaxol, using Phospho-(Ser) CDKs Substrate Antibody.

IP

IP

Western blot analysis of extracts from NIH/3T3 cells immunoprecipitated with either Phospho-(Ser) CDKs Substrate Antibody (lane 1) or Phospho-Rb (Ser807/811) Antibody #9308 (lane 2) and then immunoblotted with Phospho-Rb (Ser807/811) Antibody #9308.

IHC-P (paraffin)

IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded human breast carcinoma, using Phospho-(Ser) CDKs Substrate Antibody .


IHC-P (paraffin)

IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded human colon carcinoma, using Phospho-(Ser) CDKs Substrate Antibody .

IHC-P (paraffin)

IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded human colon carcinoma control (left) or lambda-phosphatase-treated (right), using Phospho-(Ser) CDKs Substrate Antibody.

ELISA-Peptide

ELISA-Peptide

Phospho-(Ser) CDKs Substrate Antibody ELISA Assay: Signal-to-noise ratio of phospho- versus nonphospho-peptides. (S* denotes phosphorylated serine.)


Background

Cyclin-dependent kinases (CDKs) are a family of Ser/Thr kinases that regulate cell-cycle transitions through their association and subsequent phosphorylation of targets in a strictly ordered fashion (1). The substrates for CDKs are proline-directed. The consensus amino acid sequence for CDK substrate is (K/R)(S*)PX(K/R), where X denotes any one of the 20 amino acids (2-4) and S* is the phosphorylation site. Phospho-(Ser) CDKs Substrate Antibody recognizes phosphorylated CDK substrates at their consensus motif, providing a powerful tool for CDK target discovery and characterization as well as HTS drug screening for potential kinase regulators.

  1. Morgan, D.O. (1997) Annu Rev Cell Dev Biol 13, 261-91.
  2. Songyang, Z. et al. (1996) Mol Cell Biol 16, 6486-93.
  3. Songyang, Z. (1999) Prog Biophys Mol Biol 71, 359-72.
  4. Holmes, J.K. and Solomon, M.J. (1996) J Biol Chem 271, 25240-6.

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!

Companion Products

License/Use Restrictions: Use of CST Motif Antibodies within certain methods (e.g., U.S. Patent No.'s 7,198,896 & 7,300,753) may require a license from CST. For information regarding academic licensing terms please have your technology transfer office contact CST Legal Department at CST_ip@cellsignal.com. For information regarding commerical licensing terms please contact CST Business Development at cbunker@cellsignal.com.

Product Pathways

Drug Discovery Tools

Featured Technologies

Protein Classes